Showing 1 - 20 results of 22 for search 'Renato Bassan', query time: 0.05s Refine Results
  1. 1
    DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA by Sabina Chiaretti, Gina Zini, Renato Bassan

    Published 2014-10-01
    Get full text
    Article
  2. 2
    Inclusion and response criteria for clinical trials in relapsed/refractory acute lymphoblastic leukemia and usefulness of historical control trials

    Inclusion and response criteria for clinical trials in relapsed/refractory acute lymphoblastic leukemia and usefulness of historical control trials by Nicola Gökbuget, Herve Dombret, Renato Bassan, Martha Wadleigh, Michael Doubek, Josep Ribera

    Published 2017-03-01
    Get full text
    Article
  3. 3
    A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia

    A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia by Renato Bassan, Monika Brüggemann, Hoi-Shen Radcliffe, Elizabeth Hartfield, Georg Kreuzbauer, Sally Wetten

    Published 2019-10-01
    Get full text
    Article
  4. 4
    MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

    MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS by Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan

    Published 2015-01-01
    Get full text
    Article
  5. 5
    PROGNOSTIC SIGNIFICANCE AND TREATMENT IMPLICATIONS OF MINIMAL RESIDUAL DISEASE STUDIES IN PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

    PROGNOSTIC SIGNIFICANCE AND TREATMENT IMPLICATIONS OF MINIMAL RESIDUAL DISEASE STUDIES IN PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA by Orietta Spinelli, Manuela Tosi, Barbara Peruta, Marie Lorena Guinea Montalvo, Elena Maino, Anna Maria Scattolin, Margherita Parolini, Piera Viero, Alessandro Rambaldi, Renato Bassan

    Published 2014-08-01
    Get full text
    Article
  6. 6
    Next‐generation sequencing for BCR‐ABL1 kinase domain mutations in adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A position paper

    Next‐generation sequencing for BCR‐ABL1 kinase domain mutations in adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A position paper by Simona Soverini, Francesco Albano, Renato Bassan, Francesco Fabbiano, Felicetto Ferrara, Robin Foà, Attilio Olivieri, Alessandro Rambaldi, Giuseppe Rossi, Simona Sica, Giorgina Specchia, Adriano Venditti, Giovanni Barosi, Fabrizio Pane

    Published 2020-05-01
    Get full text
    Article
  7. 7
    Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study

    Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study by Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-Maria Ribera, Renato Bassan, Andrey N. Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi

    Published 2023-01-01
    Get full text
    Article
  8. 8
    Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia

    Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leu... by Orietta Spinelli, Barbara Peruta, Manuela Tosi, Vittoria Guerini, Anna Salvi, Maria Cristina Zanotti, Elena Oldani, Anna Grassi, Tamara Intermesoli, Caterina Micò, Giuseppe Rossi, Pietro Fabris, Giorgio Lambertenghi-Deliliers, Emanuele Angelucci, Tiziano Barbui, Renato Bassan, Alessandro Rambaldi

    Published 2007-05-01
    Get full text
    Article
  9. 9
    P1183: CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS AND AT RELAPSE IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS OF THE “RETE EMATOLOGICA VENETA” (T-REV PROJECT).

    P1183: CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS AND AT RELAPSE IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS OF THE “RETE EMATOLOGICA VENETA” (T-REV... by Marcello Riva, Maria Chiara Tisi, Davide Facchinelli, Greta Scapinello, Alberto Schena, Dario Marino, Silvia Finotto, Leila Romano, Maurizio Cavallari, Carlo Borghero, Renato Bassan, Mauro Krampera, Filippo Gherlinzoni, Livio Trentin, Alberto Tosetto, Piero Maria Stefani, Francesco Piazza, Carlo Visco

    Published 2023-08-01
    Get full text
    Article
  10. 10
    Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival

    Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survi... by Silvia Salmoiraghi, Marie Lorena Guinea Montalvo, Greta Ubiali, Manuela Tosi, Barbara Peruta, Pamela Zanghi, Elena Oldani, Cristina Boschini, Alexander Kohlmann, Silvia Bungaro, Tamara Intermesoli, Elisabetta Terruzzi, Emanuele Angelucci, Irene Cavattoni, Fabio Ciceri, Renato Bassan, Alessandro Rambaldi, Orietta Spinelli

    Published 2016-06-01
    Get full text
    Article
  11. 11
    High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program

    High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program by Tamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, Federica Delaini, Claudio Romani, Enrico Maria Pogliani, Chiara Pagani, Emanuele Angelucci, Elisabetta Terruzzi, Alessandro Levis, Vincenzo Cassibba, Daniele Mattei, Giacomo Gianfaldoni, Anna Maria Scattolin, Eros Di Bona, Elena Oldani, Margherita Parolini, Nicola Gökbuget, Renato Bassan

    Published 2013-11-01
    Get full text
    Article
  12. 12
    Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

    Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study by Andrea Visentin, Vincenzo Nasillo, Monia Marchetti, Isacco Ferrarini, Rossella Paolini, Rosaria Sancetta, Gian Matteo Rigolin, Francesca Cibien, Marcello Riva, Chiara Briani, Serena Marinello, Francesco Piazza, Filippo Gherlinzoni, Mauro Krampera, Renato Bassan, Antonio Cuneo, Mario Luppi, Gianpietro Semenzato, Roberto Marasca, Livio Trentin

    Published 2020-06-01
    Get full text
    Article
  13. 13
    CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease

    CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease by Francesco Mannelli, Giacomo Gianfaldoni, Tamara Intermesoli, Chiara Cattaneo, Erika Borlenghi, Sergio Cortelazzo, Irene Cavattoni, Enrico Maria Pogliani, Monica Fumagalli, Emanuele Angelucci, Claudio Romani, Fabio Ciceri, Consuelo Corti, Anna Scattolin, Agostino Cortelezzi, Daniele Mattei, Ernesta Audisio, Orietta Spinelli, Elena Oldani, Alberto Bosi, Alessandro Rambaldi, Renato Bassan

    Published 2012-04-01
    Get full text
    Article
  14. 14
    International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

    International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia by Nicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, Adele K. Fielding, Anjali Advani, Renato Bassan, Victoria Chia, Michael Doubek, Sebastian Giebel, Dieter Hoelzer, Norbert Ifrah, Aaron Katz, Michael Kelsh, Giovanni Martinelli, Mireia Morgades, Susan O’Brien, Jacob M. Rowe, Julia Stieglmaier, Martha Wadleigh, Hagop Kantarjian

    Published 2016-12-01
    Get full text
    Article
  15. 15
    Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma

    Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma by Nicola Gökbuget, Christina-Maria Hartog, Renato Bassan, Heinz-Gerd Derigs, Herve Dombret, Richard Greil, Jesus-Maria Hernández-Rivas, Francoise Huguet, Tamara Intermesoli, Eric Jourdan, Christian Junghanss, Lothar Leimer, Maria-Jose Moreno, Albrecht Reichle, Josep Ribera, Matthias Schmid, Hubert Serve, Matthias Stelljes, Reingard Stuhlmann, Dieter Hoelzer

    Published 2011-02-01
    Get full text
    Article
  16. 16
    Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia

    Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia by Renato Bassan, Arianna Masciulli, Tamara Intermesoli, Ernesta Audisio, Giuseppe Rossi, Enrico Maria Pogliani, Vincenzo Cassibba, Daniele Mattei, Claudio Romani, Agostino Cortelezzi, Consuelo Corti, Anna Maria Scattolin, Orietta Spinelli, Manuela Tosi, Margherita Parolini, Filippo Marmont, Erika Borlenghi, Monica Fumagalli, Sergio Cortelazzo, Andrea Gallamini, Rosa Maria Marfisi, Elena Oldani, Alessandro Rambaldi

    Published 2015-06-01
    Get full text
    Article
  17. 17
    CEBPA–double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features

    CEBPA–double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features by Francesco Mannelli, Vanessa Ponziani, Sara Bencini, Maria Ida Bonetti, Matteo Benelli, Ilaria Cutini, Giacomo Gianfaldoni, Barbara Scappini, Fabiana Pancani, Matteo Piccini, Tommaso Rondelli, Roberto Caporale, Anna Maria Grazia Gelli, Benedetta Peruzzi, Marco Chiarini, Erika Borlenghi, Orietta Spinelli, Damiano Giupponi, Pamela Zanghì, Renato Bassan, Alessandro Rambaldi, Giuseppe Rossi, Alberto Bosi

    Published 2017-03-01
    Get full text
    Article
  18. 18
    Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06

    Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 by Chiara Caprioli, Federico Lussana, Silvia Salmoiraghi, Roberta Cavagna, Ksenija Buklijas, Lara Elidi, Pamela Zanghi', Anna Michelato, Federica Delaini, Elena Oldani, Tamara Intermesoli, Anna Grassi, Giacomo Gianfaldoni, Francesco Mannelli, Dario Ferrero, Ernesta Audisio, Elisabetta Terruzzi, Lorella De Paoli, Chiara Cattaneo, Erika Borlenghi, Irene Cavattoni, Monica Tajana, Anna Maria Scattolin, Daniele Mattei, Paolo Corradini, Leonardo Campiotti, Fabio Ciceri, Massimo Bernardi, Elisabetta Todisco, Agostino Cortelezzi, Brunangelo Falini, Chiara Pavoni, Renato Bassan, Orietta Spinelli, Alessandro Rambaldi

    Published 2020-08-01
    Get full text
    Article
  19. 19
    Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

    Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEM... by Sabina Chiaretti, Monica Messina, Irene Della Starza, Alfonso Piciocchi, Luciana Cafforio, Marzia Cavalli, Akram Taherinasab, Michela Ansuinelli, Loredana Elia, Guglielmo Albertini Petroni, Roberta La Starza, Martina Canichella, Alessia Lauretti, Maria Cristina Puzzolo, Valentina Pierini, Alessandra Santoro, Orietta Spinelli, Valerio Apicella, Saveria Capria, Francesco Di Raimondo, Paolo De Fabritiis, Cristina Papayannidis, Anna Candoni, Roberto Cairoli, Marco Cerrano, Nicola Fracchiolla, Daniele Mattei, Chiara Cattaneo, Antonella Vitale, Enrico Crea, Paola Fazi, Cristina Mecucci, Alessandro Rambaldi, Anna Guarini, Renato Bassan, Robin Foà

    Published 2020-05-01
    Get full text
    Article
  20. 20
    P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA

    P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA by Adriano Venditti, Alfonso Piciocchi, Luca Maurillo, Maria Ilaria Del Principe, Raffaele Palmieri, Stefano Soddu, Federico Moretti, Prassede Salutari, Maurizio Martelli, Maria Paola Martelli, Mario Luppi, Alessandro Pulsoni, Francesco Zaja, Roberto Cairoli, Fabrizio Pane, Sergio Siragusa, Renato Bassan, Michela Rondoni, Milena Mirabile, Antonino Mulè, Germana Beltrami, Patrizia Zappasodi, Laura Cudillo, Andrea Mengarelli, Antonio Curti, Felicetto Ferrara, Giovanni Rossi, Ernesta Audisio, Giuseppina Spinosa, Alessia Tieghi, Monica Bocchia, Vincenza Martini, Catello Califano, Luigi Rigacci, Agostino Tafuri, Michele Gottardi, Paola Fazi, Marco Vignetti, Francesco Buccisano

    Published 2023-08-01
    Get full text
    Article

Search Tools: